Originally published In Press as doi:10.1074/jbc.M204784200 on July 11, 2002
J. Biol. Chem., Vol. 277, Issue 39, 35920-35931, September 27, 2002
Involvement of an Upstream Stimulatory Factor as Well as
cAMP-responsive Element-binding Protein in the Activation of
Brain-derived Neurotrophic Factor Gene Promoter I*
Akiko
Tabuchi
§,
Hidemichi
Sakaya
,
Tomochika
Kisukeda
,
Hiroshi
Fushiki
, and
Masaaki
Tsuda
§¶
From the
Department of Biological Chemistry, Faculty
of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical
University, Sugitani 2630, Toyama 930-0194 and § Core
Research for Evolutional Science and Technology (CREST), Japan Science
and Technology Corporation, Shibuya 3-13-11,
Tokyo 150-0002, Japan
Received for publication, May 16, 2002, and in revised form, July 1, 2002
 |
ABSTRACT |
The use of different brain-derived neurotrophic
factor (BDNF) gene promoters results in the differential production of
5'-alternative transcripts, suggesting versatile functions of BDNF in
neurons. Among four BDNF promoters I, II, III, and IV (BDNF-PI, -PII,
-PIII, and -PIV), BDNF-PI was markedly activated, as well as BDNF-PIII, by Ca2+ signals evoked via neuronal activity.
However, little is known about the mechanisms for the transcriptional
activation of BDNF-PI. Using rat cortical neurons in culture, we
assigned the promoter sequences responsible for the Ca2+
signal-mediated activation of BDNF-PI and found that the
Ca2+-responsive elements were located in two separate
(distal and proximal) regions and that the DNA sequences in the
proximal region containing cAMP-responsive element (CRE), which is
overlapped by the upstream stimulatory factor (USF)-binding element,
were largely responsible for the activation of BDNF-PI. CRE-binding protein (CREB) family transcription factors and USF1/USF2 bind to this
overlapping site, depending upon their preferred sequences which also
control the magnitude of the activation. Overexpression of dominant
negative CREB or USF reduced the BDNF-PI activation. These findings
support that not only CREB but also USF1/USF2 contributes to
Ca2+ signal-mediated activation of BDNF-PI through the
recognition of an overlapping CRE and USF-binding element.
 |
INTRODUCTION |
Brain-derived neurotrophic factor
(BDNF),1 a member of the
neurotrophin family, plays an important role in promoting neuronal survival, neuronal differentiation, and synaptic plasticity (1). BDNF
is predominantly expressed in the central nervous system, and its
mRNA expression is up-regulated by neuronal activity accompanying the influx of Ca2+ into neurons (2, 3). The BDNF gene
consists of four short 5'-exons (exons I, II, III, and IV) and a common
3'-exon V encoding a prepro-BDNF protein (4). Four promoters, BDNF-PI,
II, III, and IV, were mapped upstream of the 5'-exons, respectively,
which are differentially regulated by kainic acid-induced seizure in distinct regions of the rat brain (5), suggesting versatile BDNF
functions in the brain (6). Therefore, elucidating the regulatory
mechanisms of BDNF gene transcription will provide a better
understanding of BDNF functions in the brain.
We previously reported that BDNF-PI and -PIII were differentially
activated by Ca2+ signals evoked via two distinct
Ca2+ entry sites, the L-type voltage-dependent
Ca2+ channel (L-VDCC) and the
N-methyl-D-aspartate glutamate receptor (NMDA-R)
(7). BDNF-PI mainly responds to Ca2+ signals evoked via
L-VDCC, whereas BDNF-PIII reacts to those evoked via either NMDA-R or
L-VDCC but less to those via NMDA-R, suggesting that the
transcriptional mechanisms initiated in response to Ca2+
signals evoked via Ca2+ channels, at least in part, differ
between BDNF-PI and -PIII. It has already been reported that the
binding of cAMP-responsive element (CRE)-binding protein (CREB) to CRE
on BDNF-PIII is required for the Ca2+ responsiveness of
BDNF-PIII (8, 9). Quite recently, however, novel
Ca2+-responsive elements (CaREs) of BDNF-PIII have been
characterized and three CaREs, called CaRE1, CaRE2, and CaRE3 (or CRE),
identified within a stretch of 170 bp upstream of exon III (10, 11). In
addition to CREB, which specifically binds to CaRE3 (or CRE), a novel
calcium-responsive transcription factor, which specifically binds to
CaRE1, has been found to drive the neuronal specific activation of
BDNF-PIII in response to the Ca2+ signals (11). However, it
is still unknown whether the CREB or another transcription factor is
involved in the activation of BDNF-PI.
In the present study, we assigned the Ca2+-responsive DNA
elements of BDNF-PI and identified the transcription factors binding to
these responsive elements. As a result, we found that not only the CREB
family transcription factors but also the upstream stimulatory factor
(USF) bound to the responsive site on which the CRE and the USF-binding
element overlap each other. It is well established that CREB is a
transcription factor, which conveys intracellular Ca2+
signals to the gene through its phosphorylation at Ser-133 (12, 13). On
the other hand, USF transcription factors encoded by two distinct genes
(USF1 and USF2) are basic helix-loop-helix/leucine zipper family
members, which preferentially interact with the E-box (5'-CANNTG-3') or
with the consensus USF-binding element (5'-GGTCACGTGACC-3') (14, 15).
USF-binding sites have been found in a number of cellular genes, which
are recognized by the USF homodimer, the USF1/USF2 heterodimer, or some
other heterodimer in combination with other transcription factors (16,
17). However, it is still not clear whether USFs are involved in the activation of gene transcription in response to the Ca2+
signals evoked via Ca2+ influx into cells. Here we
demonstrated a unique contribution of USFs to the Ca2+
signal-mediated activation of BDNF-PI, which bind to the DNA sequences
overlapped by CRE.
 |
EXPERIMENTAL PROCEDURES |
Antibodies--
Antibodies used for the supershift assay were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). These were as
follows: rabbit polyclonal antibody against ATF2 (N-96), C/EBP
(C-19), C/EBP
(C-22), the CREB/CREM family (X-12) (which partially
cross-reacts with other ATF/CREB and CREM families), c-Fos (D-1), Fra1
(N-17), USF1 (C-20), and USF2 (N-18) and mouse monoclonal antibody
against ATF1 (C41-5.1) (which specifically reacts with ATF1, but not
with other ATF/CREB transcription factors). Additionally, mouse
monoclonal antibody against the CREB family (25C10G) (not specific for
ATF1) reacts with ATF1, CREB and CREM; furthermore, mouse monoclonal antibody against CREB (24H4B) specifically reacts with CREB, but not
with other ATF/CREB transcription factors. Normal IgG was also used as
a control.
Cell Culture--
Primary cultures of rat cortical neurons were
prepared from the cerebral cortexes of 17-18-day-old rat
(Sprague-Dawley) embryos as described previously (18). Briefly, small
pieces of cerebral cortex were dissected by enzymatic (DNase I (Sigma)
followed by trypsin (Sigma)) treatment and mechanical dissociation, and
the cells were seeded at 5 × 106 cells in a 60-mm
culture dish (Iwaki). The cells were grown for 48 h in Dulbecco's
modified Eagle's medium (Nissui) containing 10% fetal calf serum, and
then the medium was replaced with serum-free Dulbecco's modified
Eagle's medium containing glucose (4.5 mg/ml), transferrin (5 µg/ml), insulin (5 µg/ml), sodium selenite (5 µg/ml), bovine
serum albumin (1 mg/ml), and kanamycin sulfate (100 µg/ml) (TIS
medium). Cytosine arabinoside (Sigma) was also added at 2 µM to prevent the proliferation of glial cells. The
medium was replaced with fresh TIS medium, but devoid of cytosine
arabinoside, 2 h before DNA transfection.
RNA Isolation and Reverse Transcription (RT)-PCR--
Total RNA
was extracted from the cultured cells using ISOGEN (NipponGene). RT-PCR
was performed as described previously (19). Briefly, total RNA (1 µg)
was reverse transcribed into cDNA in 20 µl of 1× first strand
buffer containing 0.5 µM oligo(dT)15 (5'-AAGCTTTTTTTTTTV-3') as a primer, 200 units of SuperScript II
reverse transcriptase (Invitrogen, Lifetech Oriental), 400 µM dNTPs, and 10 units of RNase inhibitor (Invitrogen,
Lifetech Oriental) as recommended by the manufacturer. After reverse
transcription, the reaction mixture was treated with 1.1 units of RNase
H (Invitrogen) at 37 °C for 20 min and used for PCR as cDNA
solution. PCR was performed in 50 µl of 1× PCR buffer containing 1 µl of cDNA solution, 1.25 units of AmpliTaq Gold DNA polymerase
(PerkinElmer Life Sciences), 1.5 mM MgCl2, 200 µM dNTPs, and 0.5 µM primer pair. To
distinguish four alternative exons (exon I, exon II, exon III, and exon
IV) of the rat BDNF gene, E-I (5'-ACTCAAAGGGAAACGTGTCTCT-3'),
E-II (5'-CGGTGTAGGCTGGAATAGACT-3'), E-III
(5'-CTCCGCCATGCAATTTCCACT-3'), E-IV (5'-GTGACAACAATGTGACTCCACT-3'), and
E-Vas (5'-GCCTTCATGCAACCGAAGTA-3') were used. For the internal
control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was
amplified using GAPDH sense (5'-TCCATGACAACTTTGGCATTGTGG-3') and
antisense (5'-GTTGCTGTTGAAGTCGCAGGAGAC-3') primers. For
amplification of BDNF cDNA, the PCR conditions, after
preheating at 95 °C for 10 min, were as follows: denaturation at
94 °C for 1 min, annealing at 55 °C for 1 min, and extension at
72 °C for 1.5 min for 32 (exon I), 31 (exon II), 26 (exon III), and
29 (exon IV) cycles, and a final extension at 72 °C for 10 min.
GAPDH amplification was carried out for 31 cycles under the same
conditions. PCR products were separated by electrophoresis on 2%
agarose gels, and the densities of the DNA bands stained with ethidium
bromide were analyzed using a Bit-Map loader (ATTO, Japan) and
software (NIH Image 1.52).
Reporter Vectors Used for Promoter Analysis and Overexpression
Experiments--
For the promoter analysis, the luciferase reporter
vector, pGL3-BDNF promoter I (pBDNFpI), was constructed by ligation of pGL3-Basic vector (Promega) with the region (
528 to +138) of rat BDNF
gene promoter I. The procedure for plasmid construction was described
previously (18). As an internal control vector against the luciferase
experimental vector, we used Renilla luciferase vector
carrying the human elongation factor 1
promoter (pRL-EF1
) (7).
For the overexpression experiments shown in Fig. 9, we used
-galactosidase vector carrying the human elongation factor 1
promoter (EF1
-
-gal) as an internal control because pRL-EF1
itself could interfere with the assessment of firefly luciferase gene
induction (data not shown).
Plasmid pBDNFpI(
488-344) was generated by double digestion of
pGL3-BDNFpI with BglII and SpeI, and blunted with
T4 DNA polymerase (TaKaRa DNA blunting kit). The digested plasmid was
then self-ligated. pBDNFpI(
378-349) was first generated by PCR with
primers (forward A: 5'-GGATCCTCCCCTCCTAGCCTAT-3'; reverse:
5'-GCGACCGCGGCTTGAGTTGAATGAA-3') to produce the fragment
that corresponded to the upstream region from
528 to
379. After the
fragment was ligated into the SmaI site of pGL3-Basic vector
(this plasmid was termed the up-vector), another PCR fragment amplified
with primers (forward: 5'-TATCCGCGGCAACTAGTGGCTCGCCC-3'; reverse B: 5'CGCAAGCTTCCTGGGGCTGTGGCAAAGAT-3') that
corresponded to the downstream region from
348 to +138 was inserted
into the SacII and Hind III sites of the
up-vector. In the manner described above, a series of internal deletion
mutants was then constructed: pBDNFpI(
357-331) (forward A, reverse:
5'-CGACCGCGGTGTAAGCCAAGCTCTC-3'; and forward:
5'-TATCCGCGGGTGCCTCTCGCCTAGTC-3', reverse B), (
335-309) (forward A, reverse: 5'-CGCGATGGCCACTAGTTGCCCACAGGAA-3';
forward: 5'-CAATATGGCCAGTCCCTAAGAGGAAAAGGG-3', reverse B),
(
345-184) (forward A, reverse:
5'-ATTATGGGCCCACAGGAACCGGTG-3'; and forward:
5'-CGCGCTGGGCCCTAGAACAAGTCACTCC-3', reverse B),
(
277-184) (forward A, reverse:
5'-CGCGATGGCCACAACTTTCCCTT-3'; and forward:
5'-CAATATGGCCACGTCCGCTGGAGACCCTT-3', reverse B), (
277-205) (forward A, reverse:
5'-CGCGATGGCCACAACTTTCCCTT-3'; and forward:
5'-CAATATGGCCATTTGATCATCACTCACGACC-3', reverse B), (
277-223) (forward A, reverse:
5'-CGCGATGGCCACAACTTTCCCTT-3'; and forward:
5'-CAATATGGCCATCACCCCTCCCCCCC-3', reverse B), (
288-245) (forward A, reverse: 5'-GCTAGAGGCCTTTTCCTCTTAGGGACTGAT-3';
and forward: 5'-CATATAGGCCTAGAACAAGTCACTCCTGCT-3', reverse
B), (
173-154) (forward A, reverse:
5'-CGACCGCGGACGTGGTCGTGAGTGA-3'; and forward: 5'-TATCCGCGGGGGAGGGGCACGAACTTT-3', reverse B),
(
151-114) (forward A, reverse:
5'-GCTATGGCCACCATGACTAAGGG-3'; and forward:
5'-TGCGCTGGCCAAGGGAGTCACAGTGAGTT-3', reverse B),
(
107-31) (forward A, reverse:
5'-GCGCGAGGCCTTGGTAAAAAGGA-3'; and forward:
5'-CATATAGGCCTCGCGCTGCGCTTTTCTGG-3', reverse B), and
(
107-65) (forward A, reverse: 5'-
GCGCGAGGCCTTGGTAAAAAGGA-3' and forward:
5'-CATATAGGCCTGGCCCCCTCCCC-3', reverse B). The
site-directed mutagenesis for the substitution of a few bases or for
the deletion of 3-7 bases within pBDNFpI was performed using a
QuikChange site-directed mutagenesis kit (Stratagene). CRE2m, TRE1m,
TRE3m, CRE2
, TRE1
, TRE2
, and TRE3
were generated, using as
forward primers,
5'-CAGTGAGTTGGTCACGGACCTGGCTCAGAGAGGCTG-3', 5'-CCTTTTTACCAAGGGAGGACCAGTGAGTTGGTCACGTAAC-3',
5'-GGTCACGTAACTGGCGACGAGAGGCTGCCCTGG-3', 5'-GGGAGTCACAGTGAGTTGGTCTGGCTCAGAGAGGCTGCCCTG-3',
5'-GAAGTTTCCTTTTTACCAAGCAGTGAGTTGGTCACGTAACTGGC-3', 5'-CCAAGGGAGTCACAGTGAGCGTAACTGGCTCAGAGAGGCTGC-3', and
5'-CAGTGAGTTGGTCACGTAACGAGAGGCTGCCCTGGCCCC-3', respectively, and
the complementary primer pair (underlined bases are substituted
nucleotide bases). TRE2/CRE2
was generated by further deletion of 5 bases from CRE2
, using 5'-CCAAGGGAGTCACAGTGAGCTGGCTCAGAGAGGCTGCCC-3' and the complementary primer.
Expression vectors, A-CREB and A-USF, were generously provided by Dr.
C. Vinson (National Cancer Institute, National Institutes of Health,
Bethesda, MD).
DNA Transfection, Luciferase, and
-Galactosidase
Assays--
DNA transfection was carried out over 3 days in culture
and using calcium phosphate/DNA precipitation as already described (18). Briefly, the calcium phosphate/DNA precipitates were prepared by
mixing one volume (100 µl) of plasmid DNA (6 µg,
pBDNFpI:pRL-EF1
= 10:1) in a 250 mM
CaCl2 solution with an equal volume of 2× HEPES-buffered
saline (50 mM HEPES-NaOH (pH7.05), 280 mM NaCl, 1.5 mM Na2HPO4), and added to each
60-mm dish. For overexpression experiments, we used plasmid DNA (6 µg, pBDNFpI:EF1
-
-gal:expression vector = 5:1:30). The dish
was washed three times with phosphate-buffered saline and fresh TIS
medium added. After 40 h, the transfected cells were stimulated
with 25 mM KCl (25 mM KCl stimulation) or vehicle for 6 h and cell lysates were prepared.
For the dual (firefly and Renilla) luciferase assay, cell
lysates were extracted with passive lysis buffer (Promega) and used as
described previously (7). For the measurement of
-galactosidase activity as an internal control, cell lysates were extracted with 250 µl of cell lysis buffer containing 1 mM potassium
phosphate (pH 7.8), 1 mM dithiothreitol, and 0.5% Triton
X-100; 30 µl of the lysate was used for the chemiluminescence-based
-galactosidase assay (CLONTECH), and 20 µl for
the firefly luciferase assay.
Preparation of Nuclear Extracts and Electrophoretic Mobility
Shift Assay (EMSA)--
Forty hours after the medium exchange at 3 DIV, cells were stimulated with 25 mM KCl (25 mM KCl stimulation) or vehicle and incubated for 6 h.
Then, nuclear extracts were prepared as described with minor
modifications (20). EMSAs were carried out using probes corresponding
to the BDNF-PI sequence (these are indicated in Fig. 4) as reported
previously (21). Briefly, end-labeling of DNA probes was performed at
37 °C for 20 min in 10 µl of reaction mixture (6.6 mM
Tris-HCl, pH 7.4, 50 mM NaCl, 6.6 mM
MgCl2, 0.5 mM dATP, 0.5 mM dGTP,
0.5 mM dTTP, 1 mM dithiothreitol) containing 200 ng of DNA, 2 µl of [32P]dCTP, and 1 unit of Klenow
fragments. Then, DNA probes were recovered with a Sephadex G-50 column.
The DNA-protein binding reaction was carried out at 25 °C for 15 min
in 20 µl of binding buffer (20 mM HEPES-NaOH, pH 7.9, 80 mM NaCl, 0.3 mM EDTA, 0.2 mM EGTA,
0.2 mM phenylmethanesulfonyl fluoride, 10% glycerol, 2 µg of poly(dI-dC), 0.2-0.4 ng of 32P-labeled DNA probes,
and 5 µg of nuclear extract). Then, DNA-protein complexes were
separated on 4% polyacrylamide gel at 132 V for 2.5 h. The
protein concentration was determined by the method of Lowry. For
supershift EMSA, a series of antibodies (2 mg/ml) was used at a
dilution of 1:20.
 |
RESULTS |
Production of BDNF Transcripts Containing Exons I, II, III, and IV
Induced via Membrane Depolarization--
Although the complicated
structure of the BDNF gene is suggested to give rise to at least eight
species of BDNF transcript (4), it has already been reported that the
exon III-containing transcript is the major form, the expression of
which is controlled by BDNF-PIII in response to the Ca2+
signals evoked via membrane depolarization in rat cortical neurons (8,
9). In addition, we have also reported that BDNF-PI is activated by
membrane depolarization, the basal promoter activity being ~8-fold
less than that of BDNF-PIII (7, 18). To confirm whether endogenous
5'-exon specific BDNF transcripts, particularly those containing exon
I, are induced by membrane depolarization or not, we examined the
increase in each transcript by RT-PCR. To distinguish each transcript,
we designed a forward primer corresponding to exon I, II, III, or IV
and a reverse primer corresponding to the common exon V (Fig.
1A). As shown in Fig.
1B, the expression of three transcripts containing exons I,
II, and III was up-regulated by the exposure of cells to 25 mM KCl in medium (25 mM KCl stimulation), whereas the expression of the exon IV-containing transcript remained constant even after the stimulation. The minimum cycle numbers required
for detecting transcripts by RT-PCR were 32 and 26 cycles for exon I
and III, respectively (see the legend of Fig. 1), indicating that the
expression level of the exon I-containing transcript is lower than that
of the exon III-containing transcript. These findings indicate that
BDNF-PI is activated by membrane depolarization in neurons although the
expression level of the exon I-containing transcript is quite low,
compared with that of the exon III-containing transcript.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Expression of 5'-exon-specific BDNF
transcripts stimulated by membrane depolarization.
A, structure of the BDNF gene and location of primers for
RT-PCR. The BDNF gene accommodates four alternative promoters, BDNF-PI,
-PII, -PIII, and -PIV, which reside upstream of exons I, II, III, and
IV, respectively (4). Gray boxes indicate
5'-noncoding exons I, II, III, and IV; the closed
box the region coding prepro-BDNF mRNA in exon V; and
the open box the 3'-noncoding region.
Arrows indicate the positions of primers used for RT-PCR.
EI, EII, EIII, and EIV are
specific forward primers corresponding to exons I, II, III, and IV,
respectively, and the reverse primer (EV) is located in the
coding region. B, rat cortical neurons (5 DIV) were
stimulated with 25 mM KCl (25 mM KCl
stimulation), and total RNA was isolated at the times indicated (0, 6, and 12 h) and subjected to RT-PCR. The relative intensities of
amplified DNA fragment containing each exon were analyzed with an
Imaging scanner and plotted. The minimum cycle numbers required for
detecting the amplified DNA were 32, 31, 26, and 29 for exons I, II,
III and IV, respectively. The data represent the mean ± S.E. from
the experiment performed in triplicate, and the same tendency was
obtained from at least two separate experiments.
|
|
Calcium-responsive Elements Located in Two Distinct Regions of BDNF
Promoter I--
To assign the calcium (Ca2+)-responsive
elements in BDNF-PI, we constructed a series of firefly luciferase
reporter vectors containing various lengths of the promoter I region
with internal deletions (see Fig. 2) for
the measurement of promoter activity. Each vector was transfected with
Renilla luciferase control vector driven by EF1
promoter
(pRL-EF1
) into rat cortical neurons at 3 DIV. We previously reported
that the luciferase activity derived from the vector carrying the
region from
528 to +138 increased in response to the Ca2+
influx through L-VDCC, which was caused by 25 mM KCl
stimulation, suggesting the presence of Ca2+-responsive
elements within the region up to nucleotide position
528 on BDNF-PI
(18). As shown in Fig. 2, the luciferase activities of plasmid vectors
pBDNFpI(
378-349), -(
357-331), -(
335-309), -(
288-245),
and -(
151-114) were nearly as inducible as those of pBDNFpI(full).
Although the use of pBDNFpI(
488-344) decreased the luciferase
activity, the deletion of the 5'-flanking region up to
310
(pBDNFpI(
311 to +138)) did not decrease the luciferase activity,
compared with that of pBDNFpI(full) (data not shown), suggesting that
the upstream region up to
310 is not so largely involved in the
Ca2+ signal-mediated activation of BDNF-PI. In contrast,
the use of plasmid vectors pBDNFpI(
345-184), -(
377-184),
-(
377-205), and -(
377-223) resulted in a decrease in
Ca2+ responsiveness of ~40-60%, suggesting that this
region includes the Ca2+-responsive elements. In addition,
more marked decreases in Ca2+ responsiveness were observed
with the deletion mutants pBDNFpI(
107-31) and -(
107-65), also
suggesting a localization of elements responsible for a strong
Ca2+ response in this region. We called these two regions
the distal and proximal region, respectively. On the other hand,
deletion of DNA sequences from
173 to
154 (pBDNFpI(
173-154))
rather increased the luciferase activity, indicating that DNA elements which function as silencers could be located within this region.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of internal deletion on
transcriptional activation of BDNF promoter I. Firefly luciferase
reporter vectors carrying various lengths of BDNF promoter I with an
internal deletion were transfected into rat cortical neurons with
pRL-EF1 control vector at 3 DIV. Forty hours after DNA transfection,
cells were stimulated with 25 mM KCl (+) or vehicle ( ),
and incubated for 6 h. Then, cell lysates were extracted and used
for luciferase reporter assay. The structures of a series of deletion
constructs used here are illustrated on the left. An
arrow indicates the transcriptional initiation site (+1).
The open box indicates the region of exon I
(+1 ~ + 138). Luciferase in the gray box indicates
the firefly luciferase gene. The deleted regions in the BDNF promoter I
are indicated by a bent line with the nucleotide
positions. pBDNFpI(full) means the wild-type construct without any
deletion. The value of KCl-stimulated transcriptional activation of
pBDNFpI(full) was indicated as 100%. The data represent the mean ± S.E. from at least four independent experiments.
|
|
Critical Role of DNA Sequences Including the CRE-like Element and a
Few Upstream Sequences in the Activation of BDNF-PI--
As shown in
Fig. 2, the proximal region from
107 to
65 was extremely effective
in the activation of BDNF-PI. Therefore, we focused on the proximal
region and investigated which DNA sequences within this region
contribute to the activation of BDNF-PI. Using the TFSEARCH program
(www.rwcp.or.jp/papia/) (22), we found that this region contained
several candidate DNA-binding sites for transcription factors, such as
CRE- and 12-O-tetradecanoylphorbol-13-acetate -responsive
element (TRE)-like sequences (Fig.
3A). To investigate the role
of these sites in the activation of BDNF-PI, we constructed a series of
plasmid DNAs having internal mutations and deletions at the sites and
transiently transfected them into rat cortical neurons. As shown in
Fig. 3B, mutation and deletion of the downstream TRE-like
sequence (TRE3m and TRE3
) did not affect the luciferase activity,
whereas a series of mutants of the CRE-like sequence (CRE2m, CRE2
)
showed a marked decrease in luciferase activity. Deletion of the middle
TRE-like sequence which partially overlapped with CRE (TRE2
)
resulted in the same decrease as with the CRE2 mutants (CRE2m,
CRE2
). On the other hand, mutants of the upstream TRE-like sequence
(TRE1m, TRE1
) were also effective in decreasing the transcriptional
activity. However, the mutation combined with the deletion of CRE
(TRE1/CRE2
) decreased the BDNF-PI activation to almost the same
level as CRE2
, suggesting a minor contribution of upstream TRE to
the activation of BDNF-PI. Among the mutant plasmid vectors
constructed, plasmid TRE2/CRE2
with an 11-base pair deletion
containing middle TRE- and CRE-like sequences was most effective in
reducing the level of BDNF-PI activity, indicating that the DNA
containing the CRE-like sequence and a few bases upstream of this
sequence are mainly responsible for the activation of BDNF-PI.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Assignment of Ca2+-responsive
element in the proximal region of BDNF promoter I. A, the DNA sequences covering from nucleotide position 109
to 62 and the location of TRE- and CRE-like elements (designated by
TRE and CRE, respectively) indicated by the TFSEACH program are shown.
Dotted bold letters indicate the bases
substituted by mutagenesis, asterisks the deleted bases, and
dashed lines the unchanged bases. B,
mutations or deletions were introduced into the region from 109 to
62 of BDNF-PI, and the transcriptional activity was measured by
transient DNA transfection. C, the construct accommodating
the deletion of the distal region covering from 227 to 223 is shown
as distal, and that accommodating both the deletion and
mutation (CRE2m) is shown as distal/CRE2m. DNA
transfection and 25 mM KCl stimulation were carried out by
the same experimental schedule as described in the legend of Fig. 2.
The gray ellipse indicates the CRE-like sequence
(CRE-PI) and the gray rectangular box,
the TRE-like sequences. The capital letter
X in the ellipse and rectangular
box indicates destruction of the CRE- or TRE-like sequence
by mutagenesis. The value of KCl-stimulated transcriptional activation
of pBDNFpI(full) was indicated as 100%. The data represent the
mean ± S.E. from at least three independent experiments.
|
|
Additionally, we constructed a plasmid vector, pBDNFpI
(
distal/CRE2m), with both a deletion of the distal region
(
277-223) and mutation of CRE2 (Fig. 3C). Compared with
the luciferase activity of wild-type pBDNFpI(full), the activity of
distal was low, which was consistent with the data shown in Fig. 2.
On the other hand,
distal/CRE2m showed a greater decrease in
luciferase activity than
distal, the level of which was almost the
same as that of CRE2m (Fig. 3C). These results indicate that
the proximal region, rather than the distal region, mainly contributes
to the activation of BDNF-PI, induced by the Ca2+ signals
in rat cortical neurons.
Transcription Factors That Bind to the Proximal Region--
We
next investigated the transcription factors that could bind to the
proximal region. To do this, we designed four kinds of native promoter
I DNA probes (npIPb-1, -2, -3, and -4) to entirely cover the proximal
region, and we performed EMSA (Fig.
4A, a). Among these
four kinds of DNA probes, DNA binding activity was obvious with npIPb-2
and -3 probes (Fig. 4A, b). For npIPb-1 and -4 probes, however, shifted bands were only faint. An increase in DNA
binding activity induced by 25 mM KCl was observed with npIPb-1, -2, and -3, but the increase obtained with npIPb-3 was very
weak. Addition of APV, an antagonist for the
N-methyl-D-aspartate receptor (NMDA-R), or
nicardipine, an antagonist for L-VDCC, tended to reduce the DNA binding
activity of npIPb-1, -2, and -3 probes, but the reduction was very weak
with npIPb-3. The doublet of shifted bands were observed only with
probe 3.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 4.
DNA binding activities in the proximal region
and their sensitivities to CRE. A, DNA binding
activities using four kinds of DNA probes covering the proximal region.
a, nucleotide sequences covering the proximal region and
position of DNA probes for EMSA used here. Four native promoter I DNA
probes (npIPb-1, -2, -3, and -4) were designed to cover the proximal
region from - 109 to 62 of BDNF promoter I. b, EMSA for
detecting transcription factors which bind to the proximal region of
BDNF promoter I. Rat cortical neurons were stimulated with 25 mM KCl and incubated for 6 h. Nuclear extracts were
then prepared and subjected to EMSA after DNA-protein binding reaction.
Inhibitors APV (200 µM) and nicardipine (Nic.;
5 µM) were added 10 min before the 25 mM KCl
stimulation. B, competitive effect of consensus CRE
(consCRE), npIPb-3, and its mutant (npIPb-3m1) on
the DNA binding activity to npIPb-3. a, nucleotide sequences
of competitors. Bold letters indicate the
position of consensus CRE, CRE-PI, and mutated CRE-PI.
Dotted gray letters indicate the
substituted bases. b, using a labeled npIPb-3, a competitive
binding reaction was performed with a 1-, 10-, and 50-fold molar excess
of cold competitors. Arrows indicate the doublet of bands,
the upper and the lower band, and asterisks nonspecific
bands. F means free probes. The experiments were done twice,
and the same results were obtained.
|
|
To investigate whether the binding to npIPb-3 probe involves the
CRE-like sequence, we examined the competitive effect of a consensus
CRE. As shown in Fig. 4B (b), both the upper and
lower bands were gradually erased when an excess of not only the cold npIPb-3 but also consensus CRE competitors was added. The mutation of
two bases introduced into the CRE-like sequence (npIPb-3m1) failed to
affect the DNA binding (Fig. 4B, a and
b). These results indicate that the CRE-like sequence in the
proximal region functions as the CRE. The competitors containing a
consensus TRE failed to compete with the binding to npIPb-3 probe,
indicating that the TRE-like sequence on npIPb-3 was unable to function
as the TRE. However, the binding to npIPb-2 probe was reduced by an
excess of consensus TRE (data not shown), indicating that the TRE-like sequence on npIPb-2 probe functions as the TRE. These findings indicate
that the CRE-like sequence in the proximal region works as the CRE and
the proteins binding to npIPb-3 probe were different from those binding
to the npIPb-2 probe.
Binding of CREB Family Transcription Factors to the CRE of BDNF
Promoter I--
To identify the DNA-binding proteins that can bind to
the CRE-like sequence of BDNF-PI (CRE-PI), we performed EMSA using
npIPb-3 probe, in which antibodies against transcription factors were added prior to the start of the DNA-protein binding reaction. When the
anti-CREB family or anti-CREB specific antibody was added to the
mixture containing npIPb-3 probe with nuclear extracts prepared from 25 mM KCl-stimulated cortical neurons, supershifted bands were
observed but faintly (Fig. 5A,
lanes 2 and 3). When anti-ATF1,
anti-ATF2, anti-c-Fos, or anti-C/EBP
specific antibody was added to
the mixture, no shifted band was observed (Fig. 5A, lanes 4-7). When the native promoter III DNA
probe (npIIIPb) containing CRE-PIII that was previously identified as a
calcium-responsive element (CaRE3) (8, 9) was used, stronger shifted
bands than those with npIPB-3 probe were observed in the presence of anti-CREB family or anti-CREB specific antibody (Fig. 5B,
lanes 2 and 3). Anti-phosphorylated
CREB specific antibody was also effective in shifting the bands upon
EMSA (data not shown). This supershift of bands caused by anti-CREB
family or anti-CREB specific antibody was clearly observed with
consensus CRE probe (Fig. 5C, lanes 2 and 3). To test further whether the CRE-PI in the proximal region could solely function as the CRE, we used DNA probes, pICRE and
pIIICRE, in which the CRE-like sequence of BDNF-PI or -PIII was
surrounded by the same sequences as surrounded the consensus CRE. As
shown in Fig. 5, D and E (lanes
2 and 3), supershifted bands were observed in the
presence of anti-CREB family or anti-CREB specific antibody, in which
the supershift of the bands was observed at almost the same level as
that of pIIICRE probe. Thus, the CRE-PI in the proximal region of
BDNF-PI functions as the CRE by itself, which is able to introduce CREB
or CREB family proteins for binding, and its effectiveness seems to be
equal to that of BDNF-PIII. As described above, however, the level of
supershift of the bands formed on npIPb-3 probe in the presence of
anti-CREB family or anti-CREB antibody appeared to be lower than that
formed on native pIII DNA probe (Fig. 5, A and
B).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 5.
Analysis of transcription factors binding to
the proximal region using supershift EMSA. Nuclear extracts were
prepared from the cells stimulated with 25 mM KCl and were
subjected to supershift EMSA after DNA-protein binding reaction.
Antibodies (0.08 µg/ml) against the CREB family, CREB, ATF1, ATF2,
c-Fos, C/EBP , and normal IgG were added to the reaction mixture
before the DNA-protein binding reaction was started at 25 °C (see
"Experimental Procedures"). S indicates the positions of
supershifted bands. The experiments shown in A and
B were performed using the DNA probes derived from BDNF
promoter I (npIPb-3) and from BDNF promoter III including the CRE of
BDNF-PIII (from bp 36 to 29) (npIIPb), respectively. Experiments in
C-E were performed using the DNA probes containing the
consensus CRE (C), and the CRE-like sequence of BDNF-PI
(CRE-PI) (D) and of BDNF-PIII (CRE-PIII) (E),
surrounded by DNA sequences that were randomly chosen from the
nucleotide sequences of pBR322. The bold letters
in the DNA probes indicate the position of the consensus CRE, CRE-PI,
and CRE-PIII. The experiments were done twice, and the same results
were obtained.
|
|
Binding of USF to a Site Overlapping CRE--
Searching other
binding sites for known transcription factors in the proximal region of
BDNF-PI using the data base TFSEARCH, we found that the USF-binding
site (5'-TGGTCACGTAACTG-3') was located and overlapped the CRE-PI (Fig.
7A). Therefore, we next investigated whether USF could be
included in the DNA-protein complex formed on the npIPb-3 probe. As
shown in Fig. 6B, addition of
anti-USF1 or -2 specific antibody prior to the DNA-protein binding
reaction resulted in a complete disappearance of the lower band of
doublet (lanes 4 and 5). Furthermore,
addition of anti-USF1 but not anti-USF2 antibody partially erased the
upper band and slightly shifted its position downward (lane
4). The partial disappearance and downward shift of the
upper band were also observed with the consensus CRE probe (Fig.
6C, lane 4), although only the upper band was obtained with this probe. When anti-CREB family antibody was
added, supershifted bands appeared faint with npIPb-3 probe but were
clear with consensus CRE probe (Fig. 6, B and C,
lanes 2), which was consistent with the results
shown in Fig. 5 (A and C). Furthermore, using the
npIPb-3 probe or consensus CRE, anti-c-Fos antibody did not give rise
to the shifted band (Fig. 6, B and C,
lane 3). Thus, the upper band of the doublet
formed by npIPb-3 probe, at least in part, consists of CREB family
transcription proteins or, at least, CREB and the lower band of the
doublet consists of USF1/USF2 only.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 6.
Binding of USFs to the proximal region.
Supershift EMSA was performed according to the same experimental
schedule as described in the legend of Fig. 5. A, the DNA
sequences of the probes used here, consensus CRE and native promoter I
DNA probe (npIPb-3), are shown and the underlined
bold letters indicate the consensus CRE and
CRE-PI. B and C, USF1 and
USF2 indicate antibodies acting specifically against USF1
and USF2, respectively. Antibodies against the CREB family and c-Fos
were also added. The experiments were done three times, and the same
results were obtained.
|
|
Changes in DNA Binding Activities Induced by Mutations of CRE-PI
and/or the USF-binding site--
Because we found that the
CRE-PI and USF-binding site overlapped in the proximal region, we next
investigated which DNA sequences are preferentially or commonly used
for the binding of CREB family proteins or USF. For this purpose, we
introduced several substitutions of nucleotide bases in the CRE-PI and
USF-binding site by constructing four mutant DNA probes for EMSA (Fig.
7A). The npIPb-3m1 and -3m4 probes were designed to destroy both CRE-PI and the USF-binding site.
On the other hand, the npIPb-3m2 and -3m3 were designed for destruction
of the USF-binding site only. Comparing the intensities of the upper
and lower bands formed on the npIPb-3 probe, as shown in Fig.
7B, the upper band was found to disappear with npIPb-3m1 and
-3m3 but remain with npIPb-3m2 and partially so with -3m4, whereas the
lower band tended to remain with npIPb-3m1 and -3m3 but disappear with
npIPb-3m2 and -3m4. Mutation of npIPb-3m3 probe, even though it is
located outside the CRE-PI, markedly decreased the upper band, the
DNA-protein complex of which should include the CREB family. Mutation
of npIPb-3m2 probe, introduced at the 5' outside of the CRE-PI,
selectively removed the lower band but not the upper band. Taken
together, the formation of the upper band tended to be dependent upon
the 3' side sequences, and that of the lower band upon the 5' side
sequences within this region.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of mutations in CRE-PI and the
USF-binding site on DNA binding activity. EMSA was performed with
the same experimental schedule as described in the legend of Fig. 4.
A, nucleotide sequences of five DNA probes. Nucleotide bases
in open boxes are substituted. In npIPb-3m1 and
-3m4 probes, both CRE-PI and USF-binding sequences were destroyed by
mutations. In npIPb-3m2 and -3m3, the USF-binding site but not CRE-PI
was lost. B, the cells were treated with 25 mM
KCl (+) or vehicle ( ), and the nuclear extracts were prepared for
EMSA after DNA-protein binding reaction. Arrows indicate the
upper and the lower bands and asterisks nonspecific bands.
F indicates free probes. The specific radioactivity of every
mutant DNA probe was almost the same (data not shown). The experiments
were done twice, and the same results were obtained.
|
|
Transcriptional Activity of BDNF Promoter I Carrying the Mutated
CRE/USF-binding site--
Because substitutions of CRE-PI
and/or the USF-binding site affected the binding activity of CREB
family proteins and USF (Fig. 7), we constructed plasmid vectors in
which the same substitutions were introduced into the proximal region
of BDNF-PI and, then, measured transcriptional activity using transient
DNA transfection. The luciferase activity of vector pBDNFpI-3m1 (also
termed pBDNFpI-CRE2m in Fig. 3, A and B)
decreased by approximately 50% in terms of Ca2+
responsiveness (Fig. 8), which was
consistent with the data shown in Fig. 3. Mutation of npIPb-3m2, which
preferentially removed the lower band but not the upper band (Fig.
7B), resulted in a decrease of ~20% in Ca2+
responsiveness. In contrast, mutation of npIPb-3m3, by which both the
upper and the lower bands were erased (Fig. 7B), resulted in
the greatest decrease in Ca2+ responsiveness. The
luciferase activity of pBDNFpI-3m4 was almost the same as that of
pBDNFpI-3m1, whose mutation resulted in the disappearance of both the
upper and lower bands but the upper band tended to be stronger than
that for mutation of npIPb-3m3. Thus, the Ca2+
responsiveness of four reporter mutant vectors showed a good correspondence with the preferential binding of DNA probes into which
the same mutation was introduced (Figs. 7 and 8), indicating an
involvement of the transcription factors that preferentially bind to
CRE-PI and the USF-binding site in the activation of BDNF-PI.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of mutation within CRE-PI and/or the
USF-binding site on the activation of BDNF promoter I. We
constructed reporter vectors carrying the same substitutions in CRE-PI
and the USF-binding site as were introduced into the DNA probes for
EMSA (Fig. 7) and transfected them into rat cortical neurons for
measuring transcriptional activation. Cells were stimulated with 25 mM KCl (+) or vehicle ( ). Transcriptional activation was
indicated as a -fold increase of the control in which pBDNFpI(full) was
transfected and the 25 mM KCl stimulation was omitted. The
nucleotide sequences of pBDNFpI, pI-3m1, pI-3m2, pI-3m3, and pI-3m4
were shown in Fig. 7A. The data represent the mean ± S.E. from experiments performed in triplicate. The same tendency was
obtained from two independent experiments.
|
|
Effect of Dominant Negative CREB or USF on the Ca2+
Responsiveness of BDNF-PI--
To address further the crucial role of
CREB family proteins and USF in the Ca2+ signal-mediated
activation of BDNF-PI, mutant plasmid vectors of dominant negative CREB
and USF were introduced into rat cortical neurons with a reporter
vector, pBDNFpI(full). Instead of the Renilla luciferase
vector, we used another control vector carrying an EF1
promoter-driven Escherichia coli
-galactosidase gene. Overexpression of CREB M1, a mutant in which the serine-133 residue was
converted to alanine (23), inhibited the activation of BDNF promoter I
up to ~50% of the control transfected with empty vector (Fig.
9A). Overexpression of A-CREB,
a mutant with an acidic extension at the N terminus of the CREB leucine
zipper domain that could interfere with the binding of DNA and
transcriptional activation of wild-type CREB (24), or K-CREB, a mutant
with a substitution in the DNA-binding domain that could inhibit the
binding of wild-type CREB (25), decreased the activation of BDNF-PI by
~20% (Fig. 9, B and C). On the other hand,
overexpression of A-USF, a mutant with an acidic extension at the N
terminus of USF (26), resulted in a marked reduction of BDNF-PI
activity up to ~60% of the control (Fig. 9D). Combined
DNA transfection of CREB M1 and A-USF, however, tended to induce the
death of cortical neurons transfected (data not shown).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 9.
Effects of overexpression of dominant
negative CREB or USF on the activation of BDNF promoter I. The
dominant negative expression vectors of CREB M1 (A), K-CREB
(B), A-CREB (C), and A-USF (D) were
co-transfected with firefly luciferase reporter vectors carrying BDNF
promoter I and E. coli -galactosidase internal control
vectors carrying EF1 promoter into rat cortical neurons. Empty
vectors were co-transfected as a control. Forty hours after
transfection, cells were stimulated with 25 mM KCl (+) or
vehicle ( ) and incubated for another 6 h. Cell lysates were then
extracted for measuring luciferase activity. The value for the
transcriptional activation of pBDNFpI(full) obtained with 25 mM KCl was standardized to 100%. The variability in the
basal transcriptional activities is probably caused by an experimental
flexibility, which could be caused mostly by culturing conditions. The
data represent the mean ± S.E. from experiments performed in
triplicate. The same result was obtained from three independent
experiments.
|
|
 |
DISCUSSION |
Prior to the characterization of the molecular mechanisms for the
Ca2+ responsiveness of BDNF gene promoter I (BDNF-PI), we
first demonstrated using RT-PCR that not only the expression of exon
III-containing transcript but also that of the exon I-containing
transcript was induced by membrane depolarization, although the basal
expression level of the latter seems to be quite low, compared with
that of the former (Fig. 1). This observation indicates that endogenous BDNF-PI in genome DNA responds to Ca2+ signals to increase
the expression of exon I-containing transcript in rat cortical neurons.
By promoter assay using transient DNA transfection in cultures of rat
cortical neurons, in addition, we demonstrated that
Ca2+-responsive elements of BDNF-PI were located in two
regions, distal and proximal (Fig. 2). Detailed analysis of the
proximal region with deletions or mutations revealed that the CRE-like
sequence in the proximal region of BDNF-PI (CRE-PI) functioned as the
CRE (Figs. 4 and 5) and was potentially required for the activation of
BDNF-PI (Figs. 2 and 3). Besides this CRE-PI, the TRE-like sequence can
work as the TRE to bind the AP1 transcription factor because the
DNA-protein complexes formed on native promoter I DNA probe-2 (npIPb-2)
for EMSA, in which the TRE-like sequence was centered (Fig.
4A), included c-Fos (data not shown). Because this TRE-like
sequence partially overlapped not only the CRE-PI but also the
USF-binding site, however, the TRE-like sequence in native promoter I
DNA probe-3 (npIPb-3) does not seem to work as a TRE but rather as a
part of the CRE-PI and USF-binding site. On the other hand, the
upstream TRE-like sequence seems to be responsible for the activation
of BDNF-PI (Fig. 3B) but would play a minor role because the
mutant of the upstream TRE-like sequence combined with CRE-PI
(TRE1/CRE2
) had the same effect as the mutant of CRE-PI alone
(CRE2
) (Fig. 3C). The downstream TRE-like sequence was
ineffective in the activation (Fig. 3B). With respect to the
distal region, the elements involved in the Ca2+
responsiveness of BDNF-PI have not been determined. A search for these
elements using a series of plasmid vectors with a deletion or mutation
in the distal region failed to specify their location because the
Ca2+ responsiveness resulting from the distal region was
dispersed by every mutation and deletion (data not shown). As shown in
Fig. 2, in addition, the mutant plasmid with both the deletion of the distal region and the mutation of CRE-PI (
distal/CRE2m) showed the
same level of activation as that having the mutation in CRE-PI (CRE2m)
alone (Fig. 3C). These findings indicate that the proximal region could play a major role in activating BDNF-PI, whereas the
distal region has a minor role.
Focusing on the proximal region, we have identified the transcription
factors that could bind to CRE-PI. As shown in Figs. 4-6, a doublet of
shifted bands, upper and lower, were detected by EMSA using npIPb-3
probe, whereas only a single band corresponding to the upper band of
the doublet was detected with the consensus CRE, pICRE, and pIIICRE
probes (Figs. 5 and 6). The DNA binding activity responsible for the
upper band was susceptible to consensus CRE (Fig. 4B), and
the supershift of the upper band was caused by anti-CREB family or
anti-CREB specific antibody, which was faintly observed (Figs.
5A and 6B). In addition, mutations introduced into CRE-PI in the proximal region (Fig. 8) and the overexpression of
dominant negative CREB M1 decreased the level of activation of BDNF-PI
(Fig. 9). Thus, it is evident that the binding of CREB to CRE-PI, at
least in part, contributes to the activation of BDNF-PI. In addition,
the fact that the three adjacent downstream bases outside the CRE-PI in
the proximal region were required for the upper band to form on the
npIPb-3 probe (Fig. 7) but not on the consensus CRE, pICRE, or pIIICRE
probe (Figs. 5 and 6), which were effective in the transcriptional
activation of BDNF-PI (Fig. 8), may suggest that different
transcription factors as well as CREB bind to npIPb-3 probe and the
bases adjacent to the CRE-PI are required for their binding. Thus, the
DNA sequences surrounding CRE-PI seem to affect the DNA binding of CREB
and other transcription factors, which may confer some differences in
the CREB binding to CRE between BDNF-PI and -PIII.
On the other hand, the lower band of the doublet was completely
diminished by anti-USF1 or -USF2 antibody (Fig. 6B),
indicating that it was formed only by the binding of USF1 and USF2 to
the npIPb-3 probe. In support of this, the USF-binding site
(5'-TGGTCACGTAACTG-3') covered the CRE-PI
(5'-TCACGTAA-3') (Fig. 7A). These overlapping sequences are conserved in the rat, human, and mouse BDNF promoters I
(data not shown). Some mutations within the USF-binding site preferentially diminished the lower band (Fig. 7), which also decreased
the level of activation of BDNF-PI (Fig. 8). In addition, the
overexpression of dominant negative A-USF was effective in reducing the
transcriptional activation, the level of which was lower than that of
CREB M1 (Fig. 9, A and D). These findings
indicate that USF1 and/or USF2 are involved in the transcriptional
activation of BDNF-PI through their bindings to the USF-binding site.
USF1 and USF2 are members of the basic helix-loop-helix/leucine zipper
family of transcription factors and bind to DNA as homodimers or
heterodimers (16). In addition, differential splicing has been shown to
give rise to at least two isoforms, the 44-kDa USF2a and the 38-kDa
USF2b (27, 28). Therefore, the complicated formations of homodimer or
heterodimer among these transcription factors are involved in the
complex formation via the USF-binding site. USF1 has been reported to
interact with other transcription factors, such as Fos-related antigen
1 (Fra1) (17) and transcription factor II-I (29). On the other hand,
CREB is a member of the leucine zipper family that is also able to form
a homodimer or heterodimer with ATF/CREB family members or other
factors at the leucine zipper motif (30, 31). Although there are
several cases in which the CRE and the USF-binding site (or E-box)
neighbor each other (32, 33), BDNF-PI is unique because the CRE and the
USF-binding site overlap. Nevertheless, a tendency was observed for the
5'-side DNA sequences within the USF-binding site to be preferentially
used for the formation of the lower band upon EMSA, whereas the 3'-side
sequences were used for that of the upper band, i.e. a
preferential usage of the DNA sequences within the USF-binding site for
USF1/USF2 and CREB. These observations may also support the binding of
a heterodimer between CREB and USF to this overlapping site, which
should be investigated.
Overexpression of the dominant negative CREB and USF mutants, CREB M1
and A-USF, resulted in a marked reduction of BDNF-PI activation,
indicating an involvement of CREB and USF in the activation of BDNF-PI
(Fig. 9, A and D). Because CREB M1 binds to CRE
but is devoid of phosphorylation at Ser-133, the dominant negative effect of CREB M1 seems to be caused by an interference in the interaction between CREB and coactivators like CREB-binding protein (CBP) on the promoter. All three types of dominant negative CREB mutants also reduced the activation of BDNF-PIII (data not shown).
As Ca2+ signal-stimulated transcription factors other than
CREB, MEF2 and NF-AT have already been found in neuronal as well as
non-neuronal cells (34, 35), and, quite recently, calcium-responsive transcription factor has been detected in neuronal cells as a calcium-
and neuron-selective transcription factor (11). As described in the
present study, it is highly possible that USF1/USF2 also functions as a
Ca2+ signal-stimulated transcription factor in neurons. It
has been reported that the phosphorylation of USF1 enhanced its DNA
binding activity (36); quite recently, Galibert et al. (37)
reported that phosphorylation of USF1 at Thr-153 increased its
transcriptional activity. In addition, the activation of gene
transcription by USF1/USF2 could be mediated by CBP/p300 (38). Thus, it
is very likely that USF1/USF2 is phosphorylated by Ca2+
signaling pathways, such as extracellular signal-regulated
kinase/mitogen-activated protein kinase, CaM (calmodulin) kinase IV and
adenylyl cyclase/cAMP-dependent protein kinase (39), and
involved in the transcriptional activation through mediation of CBP.
For full activation of the transcription of the mouse renin gene,
co-operation between CREB/CREM and USF1/USF2 is required, in which the
CRE-like element and E-box, for the binding of CREB and USF1/USF2,
respectively, neighbor each other with an interval of ~10 bases (33).
In BDNF-PI, however, the CRE-like sequence and the USF-binding site
overlapped, suggesting a different mechanism for transcriptional
activation of BDNF-PI. Rather than co-operation by these transcription
factors for promoter activation, a competitive binding of CREB and
USF1/USF2 to this overlapping site could be considered for controlling
the BDNF-PI activation in accordance with the Ca2+
signalings evoked in neurons. Differential usage of CREB or USF1/USF2 for promoter activation in response to Ca2+ signals might
be controlled by Ca2+ signaling pathways among which
extracellular signal-regulated kinase/mitogen-activated protein kinase,
CaM kinase IV, and adenylyl cyclase/cAMP-dependent protein
kinase are activated by the influx of Ca2+ into neurons via
the NMDA-R or L-VDCC. it is important to elucidate the molecular
mechanisms of the CREB- and USF-mediated activation of BDNF-PI evoked
via Ca2+ signals in neurons for a better understanding of
the intracellular mechanisms of neuronal activity-dependent
gene expression, which might contribute to neuronal survival and plasticity.
 |
ACKNOWLEDGEMENTS |
We are very grateful to Dr. Haruhiko Bito
(Kyoto University Graduate School of Medicine, Kyoto, Japan) for
helpful discussions. We also thank Dr. Charles Vinson (National Cancer
Institute, National Institutes of Health, Bethesda, MD) for providing
A-CREB and A-USF expression vectors.
 |
FOOTNOTES |
*
This work was supported by a grant-in-aid from the Ministry
of Education, Culture, Sports, Science and Technology of the Japanese Government, by grants from Core Research for Evolutional Science and
Technology (CREST), by the Science and Technology Corporation, and by
Sasakawa scientific research grants from the Japan Science Society.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Biological Chemistry, Faculty of Pharmaceutical Sciences, Toyama
Medical and Pharmaceutical University, Sugitani 2630, Toyama
930-0194, Japan. Tel.: 81-76-434-7535; Fax: 81-76-434-5048;
E-mail: tsuda@ms.toyama-mpu.ac.jp.
Published, JBC Papers in Press, July 11, 2002, DOI 10.1074/jbc.M204784200
 |
ABBREVIATIONS |
The abbreviations used are:
BDNF, brain-derived
neurotrophic factor;
CRE, cAMP-responsive element;
CREB, cAMP-responsive element-binding protein;
USF, upstream stimulatory
factor;
BDNF-P, brain-derived neurotrophic factor promoter;
L-VDCC, L-type voltage-dependent Ca2+ channel;
RT, reverse transcription;
NMDA-R, N-methyl-D-aspartate glutamate receptor;
CaRE, Ca2+-responsive element;
DIV, days in culture;
APV, DL-amino-5-phosphonovalerate;
TRE, tetradecanoylphorbol-13-acetate -responsive element;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
CBP, cAMP-responsive
element-binding protein-binding protein;
EF1
, human elongation
factor 1
.
 |
REFERENCES |
| 1.
|
Thoenen, H.
(1995)
Science
270,
593-598[Abstract/Free Full Text]
|
| 2.
|
Ernfors, P.,
Wetmore, C.,
Olson, L.,
and Persson, H.
(1990)
Neuron
5,
511-526[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Ghosh, A.,
Carnahan, J.,
and Greenberg, M. E.
(1994)
Science
263,
1618-1623[Abstract/Free Full Text]
|
| 4.
|
Timmusk, T.,
Palm, K.,
Metsis, M.,
Reintam, T.,
Paalme, V.,
Saarma, M.,
and Persson, H.
(1994)
Neuron
10,
475-489
|
| 5.
|
Metsis, M.,
Timmusk, T.,
Arenas, E.,
and Persson, H.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
8802-8806[Abstract/Free Full Text]
|
| 6.
|
Ayoubi, T. A.,
and Van De Ven, W. J.
(1996)
FASEB J.
10,
453-460[Abstract]
|
| 7.
|
Tabuchi, A.,
Nakaoka, R.,
Amano, K.,
Yukimine, M.,
Andoh, T.,
Kuraishi, Y.,
and Tsuda, M.
(2000)
J. Biol. Chem.
275,
17269-17275[Abstract/Free Full Text]
|
| 8.
|
Tao, X.,
Finkbeiner, S.,
Arnold, D. B.,
Shaywitz, A. J.,
and Greenberg, M. E.
(1998)
Neuron
20,
709-726[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Shieh, P. B., Hu, S.-C.,
Bobb, K.,
Timmusk, T.,
and Ghosh, A.
(1998)
Neuron
20,
727-740[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
West, A. E.,
Chen, W. G.,
Dalva, M. B.,
Dolmetsch, R. E.,
Kornhauser, J. M.,
Shaywitz, A. J.,
Takasu, M. A.,
Tao, X.,
and Greenberg, M. E.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
11024-11031[Abstract/Free Full Text]
|
| 11.
|
Tao, X.,
West, A. E.,
Chen, W. G.,
Corfas, G.,
and Greenberg, M. E.
(2002)
Neuron
33,
383-395[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Sheng, M.,
Thompson, M. A.,
and Greenberg, M. E.
(1991)
Science
252,
1427-1430[Abstract/Free Full Text]
|
| 13.
|
Bito, H.,
Deisseroth, K.,
and Tsien, R. W.
(1996)
Cell
87,
1203-1214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Sirito, M.,
Lin, Q.,
Maity, T.,
and Sawadogo, M.
(1994)
Nucleic Acids Res.
22,
427-433[Abstract/Free Full Text]
|
| 15.
|
Bendall, A. J.,
and Molloy, P. L.
(1994)
Nucleic Acids Res.
22,
2801-2810[Abstract/Free Full Text]
|
| 16.
|
Sirito, M.,
Walker, S.,
Lin, Q.,
Kozlowski, M. T.,
Klein, W. H.,
and Sawadogo, M.
(1992)
Gene Exp.
2,
231-240
|
| 17.
|
Pognonec, P.,
Boulukos, K. E.,
Aperlo, C.,
Fujimoto, M.,
Ariga, H.,
Nomoto, A.,
and Kato, H.
(1997)
Oncogene
14,
2091-2098[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Tabuchi, A.,
Sano, K.,
Nakaoka, R.,
Nakatani, C.,
and Tsuda, M.
(1998)
Biochem. Biophys. Res. Commun.
253,
818-823[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Tabuchi, A.,
Koizumi, M.,
Nakatsubo, J.,
Yaguchi, T.,
and Tsuda, M.
(2001)
Neurosci. Res.
39,
85-93[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Schreiber, E.,
Matthias, P.,
Muller, M. M.,
and Schaffner, W.
(1989)
Nucleic Acids Res.
17,
6419[Free Full Text]
|
| 21.
|
Tabuchi, A., Oh, E.,
Taoka, A.,
Sakurai, H.,
Tsuchiya, T.,
and Tsuda, M.
(1996)
J. Biol. Chem.
271,
31061-31067[Abstract/Free Full Text]
|
| 22.
|
Heinemeyer, T.,
Wingender, E.,
Reuter, I.,
Hermjakob, H.,
Kel, A. E.,
Kel, O. V.,
Ignatieva, E. V.,
Ananko, E. A.,
Podkolodnaya, O. A.,
Kolpakov, F. A.,
Podkolodny, N. L.,
and Kolchanov, N. A.
(1998)
Nucleic Acids Res.
26,
364-370
|
| 23.
|
Gonzalez, G. A.,
and Montminy, M. R.
(1989)
Cell
59,
675-680[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
| |